Trial intelligence / Profile preview

Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus Added to High Risk Stratum Treatment

NCT00980460Phase 3Completed

Sponsor
National Cancer Institute
Start
Sep 2009
Primary completion
Jun 2020
Modality
Small Molecules
Countries
6
01

Overview

A Phase 3 trial of temsirolimus in hepatoblastoma, sponsored by National Cancer Institute. Started Sep 2009; status: completed.

02

Drugs

temsirolimus
03

Conditions

hepatoblastoma

Beyond the preview

Go deeper on NCT00980460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00980460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call